EXACTECH, INC.

Manufacturer adverse-event records for EXACTECH, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 1994–2026 · mid-book · typical Death-code · injury-heavy

Injury-mix signature

EXACTECH, INC. leans injury-heavy in event_type mix

Injury-coded event_type share is 90.1% (injury-heavy tercile) beside 0.07% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for EXACTECH, INC.

The standout signal for EXACTECH, INC. is Injury-mix: 90.1% Injury-coded (injury-heavy) beside 0.07% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for EXACTECH, INC.. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Injury at 18,525 (90.1% of event_type total). Peak single-year volume reaches 5,088 reports across 31 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

20,569
Total Reports
15
Event-type Death
18,525
Injury Reports
20
Device Types

Event Types

Injury 18,525 (90.1%)
Malfunction 1,308 (6.4%)
Other 697 (3.4%)
24 (0.1%)
Death 15 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 12,690 (45.3%)
Hospitalization 5,121 (18.3%)
R 3,998 (14.3%)
H 2,648 (9.5%)
1,542 (5.5%)
Other 993 (3.5%)
S 579 (2.1%)
O 218 (0.8%)
Disability 148 (0.5%)
Life Threatening 28 (0.1%)
Death 14 (0.1%)
D 6 (0.0%)
L 6 (0.0%)
Congenital Anomaly 4 (0.0%)
C 2 (0.0%)

Yearly Trend

94
1994: 1
96
1996: 3
97
1997: 11
98
1998: 9
99
1999: 2
00
2000: 17
01
2001: 13
02
2002: 25
03
2003: 26
04
2004: 21
05
2005: 19
06
2006: 20
07
2007: 42
08
2008: 47
09
2009: 71
10
2010: 159
11
2011: 77
12
2012: 87
13
2013: 169
14
2014: 578
15
2015: 331
17
2017: 712
18
2018: 986
19
2019: 705
20
2020: 1,058
21
2021: 804
22
2022: 1,807
23
2023: 3,081
24
2024: 5,088
25
2025: 3,659
26
2026: 941